Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 19, 1989 - Issue 3
13
Views
17
CrossRef citations to date
0
Altmetric
Research Article

A New Method for the Measurement of Nitrosoureas in Plasma: an H.P.L.C. Procedure for the Measurement of Fotemustine Kinetics

, , , , &
Pages 329-339 | Received 06 Sep 1988, Accepted 10 Nov 1988, Published online: 22 Sep 2008

References

  • Bartosek I., Daniel S., Sykora S. Differential pulse polarographic determination of submicrogram quantities of carmustine and related compounds in biological fluids. Journal of Pharmaceutical Sciences 1978; 67: 1160–1163
  • Bartosek I., Russo R. G., Cattaneo M. T. Pharmacokinetics of nitrosoureas: Levels of 1,3‐bis‐(2‐chloroethyl)‐1‐nitrosourea (BCNU) in organs of normal and Walker 256/B carcinoma bearing rats after i.v. bolus. Tumori 1984; 70: 491–498
  • Caddy B., Idowk G. R., Stuart J. F. A high pressure liquid chromatographic procedure for monitoring 1‐(2‐chloroethyl)‐3‐(4‐trans‐methylcyclohexyl)‐1‐nitrosourea levels on body fluids. Therapeutics and Drug Monitoring 1982; 4: 389–395
  • Colvin M., Brundtett R. B., Cowens W., Jardine I., Ludlam D. B. A chemical basis for anti‐tumour activity of chloroethylnitrosoureas. Biochemical Pharmacology 1976; 25: 695–699
  • De Vita V. T., Denham C., Davidson J. D., Oliverio V. T. The physiological disposition of the carcinostatic 1,3‐bis‐(2‐chloroethyl)‐1‐nitrosourea (BCNU) in man and animals. Clinical Pharmacology and Therapeutics 1967; 8: 566–577
  • Ings R. M. J., Pidgen A., Johnson D. Analysis of bioavailability studies. Clinical Pharmacology and Therapeutics, P. Turner, C. Padgham. Macmillan, London 1980
  • Khayat D., Lokiec F., Bizzari J. ‐P., Weil M., Meeus L., Sellami M., Rousesse J., Banzet P., Jacquillat C. Phase I clinical study of the new amino acid‐linked nitrosourea, S10036, administered on a weekly schedule. Cancer Research 1987; 47: 6782–6785
  • Krull I. S., Strauss J., Hochberg F., Zervas N. T. An improved trace analysis of N‐nitrosoureas from biological media. Journal of Analytical Toxicology 1981; 5: 42–46
  • Labarre P., Godenèche D., Madelmont J. C., Triana K., Mathe K., Veyre A. Qualitative and quantitative analysis of a new sulphur‐containing nitrosourea in blood by high performance liquid chromatography. Journal of Chromatography, Biomedical Applications 1987; 419: 381–387
  • Levin V. A., Hoffman W., Weinkam R. J. Pharmacokinetics of BCNU in man: a preliminary study of 20 patients. Cancer Treatment Reports 1978; 62: 1305–1312
  • Polacek J., Gunnarsson P. O., Brandin S. Determination of tauromustine, a nitrosourea‐based anticancer agent, in plasma by high performance liquid chromatography. Journal of Chromatography Biomedical Applications 1988; 425: 424–428
  • Reed D. J. Synthesis and characterisation of nitrosoureas. Anticancer and Interferon Agents. Synthesis and Properties, R. M. Offenbrite, G. B. Buther. Marcel Dekker, New York 1984; 177–202
  • Russo R. G., Bartosek I., Piazza E., Santi A. M., Libretti A., Garattini S. Differential pulse polarographic determination of BCNU pharmacokinetics in patients with lung cancer. Cancer Treatment Reports 1981; 65: 555–562
  • Russo R. G., Cattaneo M. T., Bartosek I. Pharmacokinetics of nitrosoureas: comparison of 1,3‐bis‐(2‐chlorethyl)‐1‐nitrosourea (BCNU) and 1‐(2‐chlorethyl)‐3‐cyclohexyl‐1 ‐nitrosourea (CCNU) after oral and intravenous administration to rats. Tumori 1984; 70: 499–502
  • Smith R., Cheung L. K. Determination of two nitrosourea antitumor agents by chemical ionization gas chromatography‐mass spectrometry. J. Chromatography Biomedical Applications 1982; 229: 464–469
  • Smith R. G., Blackstock S. C., Cheung L. K., Loo T. L. Analysis for nitrosourea antitumor agents by gas chromatography‐mass spectrometry. Analytical Chemistry 1981; 53: 1205–1208
  • Smith R. G., Cheung L. K., Feun L. G., Loo T. L. Determination of 1‐(2‐chloroethyl)‐3‐ (2,6‐dioxo‐3‐piperidyl)‐1‐nitrosourea in plasma by negative chemical ionisation mass spectrometry. Biomedical Mass Spectrometry 1983; 10: 404–407
  • Uihlein M., Sistovaris N. High performance liquid column and thin‐layer chromatographic determination of human serum glibenclamide at therapeutic levels. J. Chromatography Biomedical Applications 1982; 227: 99–101
  • Weinkam R. J., Finn A., Levin V. A., Kane J. P. Lipophilic drugs and lipoproteins: Partitioning effects on chloroethyl nitrosourea reaction rates in serum. Journal of Pharmacology and Experimental Therapeutics 1980; 214: 318–323
  • Weinkam R. J., Liu T. ‐J. Quantitation of lipophilic chloroethylnitrosourea cancer chemotherapeutic agents. Journal of Pharmacological Science 1982; 71: 152–157
  • Yeager R. L., Oldfield E. H., Chatterji D. C. Quantitation of 1,3‐bis‐(2‐chloroethyl)‐1‐ nitrosourea in plasma using high performance liquid chromatography. Journal of Chromatography, Biomedical Applications 1984; 305: 496–501

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.